Why Shares of Adaptimmune Therapeutics were Jumping

Order By

What’s going on with Adaptimmune stock Shares of Adaptimmune Therapeutics were jumping yesterday. The British cell...

Jun 28

by Stacy Brooks

KEY POINTS The first firm is currently a leader in the treatment of cystic fibrosis, and...

Jun 9

by Stacy Brooks

KEY POINTS Clovis specializes in cancer therapies and has one marketed treatment, Rubraca. Clovis, small market...

Apr 19

by Stacy Brooks

KEY POINTS Analysts are growing more optimistic about the biotech firm’s prospects. What’s going on with...

Apr 15

by Stacy Brooks

KEY POINTS In the second quarter, however, Walgreens beat forecasts by a wide margin, but that...

Apr 15

by Stacy Brooks

KEY POINTS Veru’s specialty is in cancer therapies, particularly those that target breast and prostate cancers....

Apr 14

by Stacy Brooks

KEY POINTS Pfizer stock is climbing after it announced its intention to acquire ReViral for up to...

Apr 8

by Stacy Brooks